Search for: "Bristol-Myers Squibb Company" Results 1 - 20 of 349
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
3 Apr 2018, 12:11 pm by Fitapelli Kurta
Fitapelli Kurta is interested in speaking to investors who have complaints regarding investments made in Bristol-Myers Squibb Company from January 27, 2015 until October 9, 2015. [read post]
28 Sep 2007, 12:51 pm
Article from WCVB TV/DT Boston -- Company To Pay $515M To Settle Drug Marketing Probes: Bristol-Myers Squibb Agrees To Settlement. [read post]
23 Jul 2009, 9:32 pm
By Sherri Oslick -- On Wednesday Bristol-Myers Squibb and Medarex, Inc. announced that they have entered into a definitive merger agreement by which Bristol-Myers Squibb will acquire Medarex for $2.4 billion. [read post]
2 Oct 2007, 6:53 pm
By Sherri Oslick -- Last week, Bristol-Myers Squibb Co. of Princeton, NJ announced that it would acquire biotechnology company Adnexus Therapeutics Inc. of Waltham, MA for $430 million in cash (with an additional $75 million to be paid provided Adnexus meets certain regulatory milestones). [read post]
2 Aug 2012, 1:20 pm by Securites Lawprof
Ramnarine, an executive at Bristol-Myers Squibb, with insider trading on confidential information about companies being targeted for potential acquisitions. [read post]
7 Sep 2010, 11:15 pm by By DEALBOOK
Bristol-Myers Squibb said Tuesday it had agreed to acquire ZymoGenetics, the maker of a hepatitis C drug the companies were jointly developing, for $885 million. [read post]
26 Apr 2007, 9:24 pm
By Donald Zuhn -- Bristol-Myers Squibb Co. and Pfizer Inc. announced today that the companies will be entering into two separate collaborations. [read post]
15 Feb 2016, 5:56 am by Law Offices of Jeffrey S. Glassman
According to a recent news feature from Fierce Pharma, Bristol-Myers Squibb (BMY) has reported huge profits over the past fiscal quarter. [read post]
27 Mar 2007, 5:07 am
A deal between Sanofi-Aventis, France’s largest drug company, and U.S. rival Bristol-Myers Squibb could still be in the offing. [read post]
29 Sep 2007, 9:21 pm
The United State Attorney for Massachusetts reports in a press release that "Bristol-Myers Squibb Company (BMS) and its wholly owned subsidiary, Apothecon, Inc., have agreed to pay in excess of $515 million to resolve a broad array of federal and... [read post]
19 Aug 2006, 4:49 am
A Department of Justice criminal investigation into an agreement between Bristol-Myers Squibb and generic drug-maker Apotex regarding a $40 million payment to the company to keep a generic version of Plavix, one of Bristol-Myers best selling drugs, from the market... [read post]
30 Aug 2016, 5:45 am by Adam Steinman
Yesterday the California Supreme Court issued a 4-to-3 decision in Bristol-Myers Squibb Company v. [read post]
4 Feb 2010, 7:31 am
Jhaveri, a native of India, was a Technical Operations Associate with Bristol-Myers-Squibb for a little over two years until he was fired." [read post]
8 Dec 2016, 1:09 pm by Jeffrey A. Newman
The company’s agreement with 42 other states and the District of Columbia centers on charges that Bristol-Myers Squibb promoted its Abilify anti-psychotic drug for use in children and elderly patients with dementia and Alzheimer’s disease. [read post]
7 Aug 2012, 8:10 am by Robert J. Tannous
On August 2, 2012, the Securities and Exchanges Commission ("SEC") charged an executive in the treasury department at Bristol-Myers Squibb with insider trading.  [read post]
21 Feb 2011, 7:00 am
We blogged about this case earlier here: http://wombletradesecrets.blogspot.com/2010/11/bristol-myers-squibb-employee-pleads.htmlHe pleaded guilty last year to the thefts and e-mailing samples to an undercover FBI informant posing as a potential investor in the company he hoped to form.Jhaveri has a doctorate in chemistry from Cornell University. [read post]